Moderna has begun administering its coronavirus vaccine in children ages 6 months to 12 years as part of a Phase 2/3 study dubbed KidCOVE.
Moderna begins testing COVID-19 vaccine in kids under 12
Moderna has begun administering its coronavirus vaccine in children ages 6 months to 12 years as part of a Phase 2/3 study dubbed KidCOVE.